ALLIANCE PHARMA SOLUTIONS, LLC – Trademark Portfolio
Entity Type: 16
ALLIANCE PHARMA SOLUTIONS, LLC has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 67% registration rate. The portfolio includes marks such as DELIVMEDS. Filings span 3 Nice Classification classes, with the highest activity in Class 9 (Computers & Electronics) and Class 44 (Medical Services). This trademark owner is based in LUTZ, FL.
2420 BRUNELLO TRACE
LUTZ, FL 33558
Showing of trademarks Trademarks
Trademark Classifications
ALLIANCE PHARMA SOLUTIONS, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does ALLIANCE PHARMA SOLUTIONS, LLC have?
ALLIANCE PHARMA SOLUTIONS, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does ALLIANCE PHARMA SOLUTIONS, LLC file in?
ALLIANCE PHARMA SOLUTIONS, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 44 (Medical Services), Class 39 (Transportation & Storage). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are ALLIANCE PHARMA SOLUTIONS, LLC's most well-known trademarks?
ALLIANCE PHARMA SOLUTIONS, LLC's registered trademark portfolio includes well-known marks such as DELIVMEDS. These are among 2 currently registered trademarks in the portfolio.
What is ALLIANCE PHARMA SOLUTIONS, LLC's trademark registration success rate?
ALLIANCE PHARMA SOLUTIONS, LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.